In this episode of Fireside Chat, we sat down with Albert Bourla, Chairman and CEO, Pfizer to talk about the development of a vaccine for COVID-19, their international and U.S. contribution to the battle against the pandemic, the five-point plan to rally the biopharma industry and their desire to collaborate on combating global pandemics and partnering with leading health systems in areas of shared interest.

Please note: The number of COVID-19 cases and the situation referenced in this episode were based on reported data at the time of the interview and are subject to change.
Transcription
Albert Bourla 0:03
As a leader, I think staying focused on what matters most has been essential to serve as we are living our values and supporting our employees and communities.

Gary Bisbee 0:14
That was Albert Bourla, Chairman and CEO, Pfizer. Albert was responding to a question about leadership in times of crisis. And he spoke about the importance of a laser focus by his executive leadership team and himself. I'm Gary Bisbee. And this is Fireside Chat. Earlier in his Pfizer career, Albert was Group President of Global Vaccines Oncology and Consumer Healthcare businesses. We dug into the value of vaccines and the issues related to developing a vaccine for COVID-19. He referred to Pfizer's entering for vaccine candidates into testing during April. To get to market as quickly as possible. Pfizer will concurrently modify and ramp up existing manufacturing facilities to meet the needs of the clinical trial and VA Our conversation covers Pfizer's international and US contribution to the COVID-19 battle. Pfizer's five point plan to rally the biopharma industry to collaborate on combating global pandemics and Pfizer's commitment to partnering with leading health systems and areas of shared interest. Let's welcome Albert Bourla to the microphone.

Good afternoon, Albert. We're pleased to have you on the microphone. Welcome.

Albert Bourla 1:27
Thank you very much, Gary. It's a great pleasure to be with you.

Gary Bisbee 1:30
Well, by way of background for today's conversation, again, we appreciate your being with us due to the COVID-19 outbreak. We're all facing challenges and seeking opportunities to contribute none more than Pfizer as a leading multinational pharmaceuticals and vaccines company. So to begin our convers

Welcome to the Health System CXO Podcast, sponsored by The Health Management Academy, featuring content designed for Health System Nurse Executives, Health Equity Officers and Strategy Executives provided by our company SME's - Anne Herleth, Jasmaine McClain, Ph.D. and Jackie Kimmell.

Subscribe today and receive the latest insights from the country's leading Health System CXO experts regularly, helping you remain current and guide your health system strategy with thought leadership and success.

The Health System CXO Podcast activates health system leaders towards outcomes and scalable solutions you can implement now.

About The Health Management Academy:
Since 1998, The Health Management Academy has cultivated the premier community of healthcare's most influential changemakers from the top U.S. health systems and innovative industry partners. We power more than 2,000 health system senior executives and 200 industry organizations through exceptional peer groups, original market insights, world-class leadership development programs and novel member alliances. Our industry-leading programs and solutions enable members to facilitate meaningful relationships, navigate strategic transformation and address critical industry issues. To learn more, visit hmacademy.com and follow The Health Management Academy on ...